Mark Manfredi brings over two decades of international biopharmaceutical industry leadership and cancer drug discovery ...
In seeking to buy Warner Brothers for $108 billion, Paramount is making one of the top ten largest hostile takeover bids in ...
As of Friday, December 12, Nektar Therapeutics’s NKTR share price has surged by 8.51%, which has investors questioning if ...
Learn more about whether Amneal Pharmaceuticals, Inc. or Wave Life Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Sen-Jam Pharmaceutical, a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics for inflammation-driven conditions, today announced the appointment of Rute Fernandes as ...
ASH Annual Meeting and Exposition leaves the oncology community buzzing over a series of late-breaking presentations that experts are calling 'unprecedented.' Major pharmaceutical developers such as ...
The Times of Israel on MSN
Israeli cyber startup Armis nears deal to be sold to ServiceNow for up to $7b — report
Founded in 2016, Armis has a cyberthreat exposure management platform that protects firms from risks as they connect all ...
Fintel reports that on December 11, 2025, Roth Capital initiated coverage of Ovid Therapeutics (NasdaqCM:OVID) with a Buy ...
Molecular responses continue to deepen with extended treatment duration, reaching 60% major molecular response at 21 cycles ...
Long a quieter, locally focused industry, Japanese pharma giants are increasingly looking to the rest of the world for deals.
MedPage Today on MSN
How a Rare Drug Made From Scientists' Blood Saves Babies From Botulism
When Alessandro Barbera was rushed to a California hospital with infant botulism in October, his father had barely heard of ...
Dramatically improved disease control with 21.2 months vs. 2.9 months median event-free survival (EFS) Favorablesafety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results